Skip to main content

Advertisement

Table 2 Anatomical outcomes of infants with type 1 ROP in the two groups within 6 months after primary treatment

From: Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study

Variables Group 1 (Primary IVR) Group 2 (Primary laser) p value
Eyes, 17 10  
Regression of acute ROP, n (%) 15 (88%) 7 (70%) 0.326 (Fisher’s exact test)
Additional treatment, n (%) 13 (76%) 3 (30%) 0.040*(Fisher’s exact test)
Causes
ROP persistence, n 0 3  
ROP reactivation, n 0 0  
ROP progression, n 2 0  
Avascularity in zone II or zone III 11 0  
Methods
Laser, n 13 3  
IVR, n 0 0  
Vitreoretinal surgery, n 1 0  
Unfavorable outcomes, n (%) 2 (12%) 0 (0%) 0.516 (Fisher’s exact test)
Temporally dragged retina over the nerve, n 2 0  
Retinal detachment or fold, n 0 0  
  1. GA gestational age, IVR intravitreal injection of ranibizumab, ROP retinopathy of prematurity
  2. *significant between-group difference